Table 3.
Base Case Analysis—Catheter Ablation Versus Medical Therapy
| Outcome | Mean | 95% CI |
|---|---|---|
| Cost (discounted) | ||
| CA | $64 960 | $55 715‒$75 647 |
| MED | $49 865 | $42 116‒$58 968 |
| Effectiveness (QALY, discounted) | ||
| CA | 5.63 | 4.38‒6.77 |
| MED | 5.18 | 4.06‒6.20 |
| Incremental | ||
| Cost ($CAD) | $15 095 | $10 631‒$19 806 |
| Effectiveness (QALY) | 0.45 | 0.15‒0.70 |
| Incremental cost‐effectiveness | ||
| ICER ($CAD/QALY) | $35 360 | $21 518‒$77 419 |
CIs taken from the 2.5 and 97.5 percentiles of the output distributions from probabilistic sensitivity analysis under base case assumptions. $CAD indicates Canadian dollars; CA, catheter ablation; ICER, incremental cost‐effectiveness ratio; MED, medical therapy; QALY, quality‐adjusted life‐years